TGFB1 and neoplasm: Since a group of abnormal proliferation cells with high fibrotic characteristics also exists in most tumor microenvironments in addition to being a popular target for fibrotic diseases, TGF-β signaling is also one of the most popular targets in the field of tumor immunotherapy in recent years [97].